Sharekhan's research report on Mastek
Revenue stood at $88.1 million, up 0.4% q-o-q/20.2% y-o-y in constant currency (cc), in line with our estimate of $88 million. Revenue from operations stood at Rs 725.3 crore, up 2.3% q-o-q/27% y-o-y. EBITDA margin stood at 17.5%, down 20 bps q-o-q. The 20-bps reduction was largely due to increments which was offset by currency and other operating levers. 12-month order backlog stood at Rs 1,763.9 crore ($215 million), down 2.6% q-o-q /up 9.7% y-o-y in cc. The Company added 22 new clients in Q1FY24. LTM attrition rate at 20.4% moderated by 60 bps q-o-q. Utilisation (including trainees) improved to 77.6% from 73.8% in Q4FY23, up 380 bps. Despite the near-term challenges and uncertainty, we believe the company is well-positioned on account of their comprehensive portfolio, strong UK public sector relationships, momentum in the Americas and Middle East which give them the confidence to achieve stronger and industry-leading growth.
Outlook
Hence, we upgrade the stock to Buy with a revised price target of Rs 2400. At the CMP the stock trades at 20.6/16.2x its FY24/25E EPS.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.